Protein Mis-Folding Emerges as a "Drugable" Target for Discovery of Novel Therapies for Neuropsychiatric Diseases of Aging

American Journal of Geriatric Psychiatry

Volumn 12, Issue 2, 2004, Pages 134-135

  Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; AMYLOIDOSIS; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN DEGENERATION; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DOWN SYNDROME; HUMAN; NEUROPSYCHIATRY; NOTE; PARKINSON DISEASE; PATHOGENESIS; PRION DISEASE; PROTEIN FOLDING; PROTEIN TARGETING; TAUOPATHY;

EID: 1342280571     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200403000-00004     Document Type: Note

References (7)

1. Bucciantini M, Giannoni E, Chiti F, et al: Inherent toxicity of aggregates implies a common mechanism of protein mis-folding disease. Nature 2002; 416:507-511
2. Giasson BI, Lee VM-Y, Trojanowski JQ: Interactions of amyloidogenic proteins. Neuro Molec Med 2003; 4:49-58
3. Taylor JP, Hardy J, Fischbeck KH: Toxic proteins in neurodegenerative disease. Science 2002; 296:1991-1995
4. Trojanowski JQ, Mattson MP: Overview of protein aggregation in single, double, and triple neurodegenerative brain amyloidoses. Neuro Molec Med 2003; 4:1-5
5. Bonini NM: Chaperoning brain degeneration. Proc Natl Acad Sci U S A 2002; 99:16407-16411
6. Loo TW, Clarke DM: Application of chemical chaperones to the rescue of folding defects. Meth Mol Biol 2003; 232:231-244
7. Soto C: Unfolding the role of protein mis-folding in neurodegenerative diseases. Nat Rev Neurosci 2003; 4:49-60